Abstracts tagged "Temporal arteritis and ultrasound"

Abstract Number: 909 • 2014 ACR/ARHP Annual Meeting
A Diagnostic Protocol for Giant Cell Arteritis (GCA) Using Ultrasound Assessment
Jennifer Piper¹, Ana Sofia Serafim¹, Cristina Ponte¹, Surjeet Singh², Bhaskar Dasgupta³, Wolfgang A. Schmidt⁴, Eugene McNally⁵, Andreas P. Diamantopoulos⁶, Andrew Hutchings⁷ and Raashid Luqmani⁸, ¹Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ²University of Oxford, Sciences, Oxford, England, ³Department of Rheumatology, Southend University Hospital, Essex, United Kingdom, ⁴Rheumatology, Immanuel Krankenhaus, Berlin, Germany, ⁵Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University, Oxford, United Kingdom, ⁶Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, ⁷Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, ⁸Oxford NIHR Musculoskeletal Biomedical Research Unit, Oxford, United Kingdom
Background/Purpose Ultrasound (US) has not yet superseded temporal artery biopsy as a diagnostic test. This may reflect poor consistency of the scanning technique, due to…
Abstract Number: 2351 • 2012 ACR/ARHP Annual Meeting
Correlation Between Hypoechoic Halo of the Temporal Arteries and Clinical, Laboratory, and Temporal Artery Biopsy Findings in Patients with Giant Cell Arteritis
Luigi Boiardi¹, Giulia Pazzola², Alberto Cavazza³, Francesco Muratore², Giovanna Restuccia², Alberto Nicolini⁴, Giuseppe Germanò², Nicolo Pipitone², Pierluigi Macchioni², Niccolò Possemato², Gianluigi Bajocchi⁵, Ilaria Padovano², Olga Addimanda⁶, Alberto Lo Gullo², Maria Grazia Catanoso⁷ and Carlo Salvarani⁸, ¹Rheumatology service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, ²Rheumatology Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, ³Pathology Unit, Arcispedale S Maria Nuova, Reggio Emilia, Italy, ⁴Internal Medicine, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, ⁵Department of Internal Medicine, Rheumatology Unit, Arcispedale S Maria Nuova. IRCCS, Reggio Emilia, Italy, ⁶Rheumatolgy Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, ⁷Rheumatology Service, Arcispedale S Maria Nuova, Reggio Emilia, Italy, ⁸Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy
Background/Purpose: The presence of a hypoechoic halo of the temporal arteries on Color-Doppler sonography (CDS) has high specificity and acceptable sensitivity for the diagnosis of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].